Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-11

Clinical Trial Update: Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1 [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study examining potential interactions between methamphetamine and selegiline in individuals with amphetamine-rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methamphetamine (methamphetamine)
  • Selegiline (selegiline)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Amphetamine-Related Disorders | Phase 1 | Status: UNKNOWN